Providers can discuss both brand-name and compounded options when appropriate with transparent pricing and clear information about how compounded semaglutide differs from FDA-approved medications Transparent flat-rate pricing includes comprehensive care - First-month discounts available, FSA/HSA eligible, no hidden consultation fees 24/7 care team provides ongoing adjustments and support - Unlimited messaging, dose modifications, meal plans, and community access included Edens telehealth model delivers high-quality care comparable to traditional weight loss clinics but with greater convenience, predictable pricing, and continuous support throughout your weight management journey

A retrospective study conducted at the University Health Network found that, in liver transplant recipients with diabetes, combination therapy reduced HbA1c and alanine aminotransferase levels more effectively than DPP-4 inhibitors. Additionally, two clinical trials in patients with Type 2 diabetes demonstrated that combination therapy significantly lowered HbA1c by 1.34% and 1.21%, compared to a 0.54% reduction with placebo, starting from a baseline of 8.0%. These findings suggest that combination therapy may be especially beneficial in the liver transplant population, where patients often experience weight gain and develop metabolic co-morbidities
Combining high protein + exercise is the strongest approach
These results dont invalidate testing